337 related articles for article (PubMed ID: 25654651)
1. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
2. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
3. Shedding light on prion disease.
Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
Prion; 2015; 9(4):244-56. PubMed ID: 26186508
[TBL] [Abstract][Full Text] [Related]
4. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
6. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.
Mohammadi B; Song F; Matamoros-Angles A; Shafiq M; Damme M; Puig B; Glatzel M; Altmeppen HC
Cell Tissue Res; 2023 Apr; 392(1):215-234. PubMed ID: 35084572
[TBL] [Abstract][Full Text] [Related]
7. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
8. Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.
Chen C; Lv Y; Zhang BY; Zhang J; Shi Q; Wang J; Tian C; Gao C; Xiao K; Ren K; Zhou W; Dong XP
Mol Neurobiol; 2014 Dec; 50(3):875-87. PubMed ID: 24771043
[TBL] [Abstract][Full Text] [Related]
9. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity.
Cissé MA; Sunyach C; Lefranc-Jullien S; Postina R; Vincent B; Checler F
J Biol Chem; 2005 Dec; 280(49):40624-31. PubMed ID: 16236709
[TBL] [Abstract][Full Text] [Related]
10. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.
Linsenmeier L; Mohammadi B; Wetzel S; Puig B; Jackson WS; Hartmann A; Uchiyama K; Sakaguchi S; Endres K; Tatzelt J; Saftig P; Glatzel M; Altmeppen HC
Mol Neurodegener; 2018 Apr; 13(1):18. PubMed ID: 29625583
[TBL] [Abstract][Full Text] [Related]
11. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo.
Endres K; Mitteregger G; Kojro E; Kretzschmar H; Fahrenholz F
Neurobiol Dis; 2009 Nov; 36(2):233-41. PubMed ID: 19632330
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal cleavage of cellular prion protein in the human brain.
Laffont-Proust I; Faucheux BA; Hässig R; Sazdovitch V; Simon S; Grassi J; Hauw JJ; Moya KL; Haïk S
FEBS Lett; 2005 Nov; 579(28):6333-7. PubMed ID: 16263114
[TBL] [Abstract][Full Text] [Related]
13. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
[TBL] [Abstract][Full Text] [Related]
14. The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.
Cissé M; Duplan E; Guillot-Sestier MV; Rumigny J; Bauer C; Pagès G; Orzechowski HD; Slack BE; Checler F; Vincent B
J Biol Chem; 2011 Aug; 286(33):29192-29206. PubMed ID: 21586567
[TBL] [Abstract][Full Text] [Related]
15. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
McDonald AJ; Dibble JP; Evans EG; Millhauser GL
J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase.
Cissé MA; Gandreuil C; Hernandez JF; Martinez J; Checler F; Vincent B
Biochem Biophys Res Commun; 2006 Aug; 347(1):254-60. PubMed ID: 16806063
[TBL] [Abstract][Full Text] [Related]
17. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific contribution of protein kinase C to prion processing.
Alfa Cissé M; Louis K; Braun U; Mari B; Leitges M; Slack BE; Fisher A; Auberger P; Checler F; Vincent B
Mol Cell Neurosci; 2008 Nov; 39(3):400-10. PubMed ID: 18722532
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
20. α-Cleavage of cellular prion protein.
Liang J; Kong Q
Prion; 2012; 6(5):453-60. PubMed ID: 23052041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
